Abstract

HIV type 1 (HIV -1) elite controllers (ECs) represent a rare group of individuals with an ability to maintain an undetectable HIV -1 viral load overtime in the absence of previous antiretroviral therapy. The mechanisms associated with this paradigm remain not clearly defined.

HIV type 1 (HIV -1) elite controllers (ECs) represent a rare group of individuals with an ability to maintain an undetectable HIV -1 viral load overtime in the absence of previous antiretroviral therapy. The mechanisms associated with this paradigm remain not clearly defined. However, loss of virological control, morbidity and mortality persist in these individuals, such as progress to AIDS-defining conditions together with persistent high rate of immune activation. Further insight into potential therapeutic options is therefore warranted. In this review, we discuss recent data on the type of immune responses understood to be associated with chronic virological control, the potential for disease progression and therapeutic options in ECs.